{"entity":{"type":"insider","cik":"0001512540","url":"/insider/0001512540","json_url":"/insider/0001512540.json","name":"Sanderling V Strategic Exit Fund LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":2,"first":"2011-12-22","last":"2012-01-11","span_basis":"filed_date"},"name_variants":[{"name":"Sanderling V Strategic Exit Fund LP","source":"filing","n_filings":2,"first_seen":"2011-12-22","last_seen":"2012-01-11"}],"transactions":[{"id":9268029,"accession":"0001209191-12-003316","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-003316","line_url":"/filing/0001209191-12-003316#line-2","is_derivative":false,"issuer_cik":"0001512540","issuer_name":"ENDOCYTE INC","issuer_ticker":"ECYT","issuer_name_source":null,"issuer_url":"/issuer/0001512540","owner_cik":null,"owner_name":"SANDERLING V BETEILIGUNGS GMBH & CO KG; SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP; SANDERLING V BIOMEDICAL LP; SANDERLING V LTD PARTNERSHIP; Sanderling V Strategic Exit Fund LP; Sanderling VI Beteiligungs GmbH & Co KG; Sanderling VI Limited Partnership; Sanderling Venture Partners V Co Investment Fund, LP; Sanderling Venture Partners V, LP; Sanderling Venture Partners VI Co Investment Fund LP","owner_display_name":"SANDERLING V BETEILIGUNGS GMBH & CO KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":197800.0,"shares_display":"197,800","price_per_share":3.16,"price_display":"3.16","price_state":"stated","total_value":625048.0,"total_display":"625,048.00","total_whole":"625,048","shares_owned_after":831461.0,"shares_owned_after_display":"831,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-12-21","filed_date":"2012-01-11","scope":"insider"},{"id":8820621,"accession":"0001209191-11-062937","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-062937","line_url":"/filing/0001209191-11-062937#line-2","is_derivative":false,"issuer_cik":"0001139814","issuer_name":"ENDOCYTE INC","issuer_ticker":"ECYT","issuer_name_source":null,"issuer_url":"/issuer/0001139814","owner_cik":null,"owner_name":"Sanderling VI Beteiligungs GmbH & Co KG; SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP; Sanderling Venture Partners V Co Investment Fund, LP; Sanderling VI Limited Partnership; SANDERLING V LTD PARTNERSHIP; SANDERLING V BIOMEDICAL LP; Sanderling V Strategic Exit Fund LP; SANDERLING V BETEILIGUNGS GMBH & CO KG; Sanderling Venture Partners V, LP; Sanderling Venture Partners VI Co Investment Fund LP","owner_display_name":"Sanderling VI Beteiligungs GmbH & Co KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":217800.0,"shares_display":"217,800","price_per_share":3.16,"price_display":"3.16","price_state":"stated","total_value":688248.0,"total_display":"688,248.00","total_whole":"688,248","shares_owned_after":871461.0,"shares_owned_after_display":"871,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-12-21","filed_date":"2011-12-22","scope":"insider"},{"id":9268028,"accession":"0001209191-12-003316","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-003316","line_url":"/filing/0001209191-12-003316#line-1","is_derivative":false,"issuer_cik":"0001512540","issuer_name":"ENDOCYTE INC","issuer_ticker":"ECYT","issuer_name_source":null,"issuer_url":"/issuer/0001512540","owner_cik":null,"owner_name":"SANDERLING V BETEILIGUNGS GMBH & CO KG; SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP; SANDERLING V BIOMEDICAL LP; SANDERLING V LTD PARTNERSHIP; Sanderling V Strategic Exit Fund LP; Sanderling VI Beteiligungs GmbH & Co KG; Sanderling VI Limited Partnership; Sanderling Venture Partners V Co Investment Fund, LP; Sanderling Venture Partners V, LP; Sanderling Venture Partners VI Co Investment Fund LP","owner_display_name":"SANDERLING V BETEILIGUNGS GMBH & CO KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":197800.0,"shares_display":"197,800","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":632960.0,"total_display":"632,960.00","total_whole":"632,960","shares_owned_after":633661.0,"shares_owned_after_display":"633,661","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-12-20","filed_date":"2012-01-11","scope":"insider"},{"id":8820619,"accession":"0001209191-11-062937","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-062937","line_url":"/filing/0001209191-11-062937#line-1","is_derivative":false,"issuer_cik":"0001139814","issuer_name":"ENDOCYTE INC","issuer_ticker":"ECYT","issuer_name_source":null,"issuer_url":"/issuer/0001139814","owner_cik":null,"owner_name":"Sanderling VI Beteiligungs GmbH & Co KG; SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP; Sanderling Venture Partners V Co Investment Fund, LP; Sanderling VI Limited Partnership; SANDERLING V LTD PARTNERSHIP; SANDERLING V BIOMEDICAL LP; Sanderling V Strategic Exit Fund LP; SANDERLING V BETEILIGUNGS GMBH & CO KG; Sanderling Venture Partners V, LP; Sanderling Venture Partners VI Co Investment Fund LP","owner_display_name":"Sanderling VI Beteiligungs GmbH & Co KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":217800.0,"shares_display":"217,800","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":696960.0,"total_display":"696,960.00","total_whole":"696,960","shares_owned_after":653661.0,"shares_owned_after_display":"653,661","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-12-20","filed_date":"2011-12-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001235007","name":"ENDOCYTE INC","url":"/issuer/0001235007","role":"Ten percent owner","n_filings":2,"first_seen":"2011-12-22","last_seen":"2012-01-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001512540","retrieved_at":"2026-08-27T06:26:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}